The American Medical Association urges greater transparency and oversight for imaging AI to maximize trust and patient safety.
Key Details
- 1AMA passed a resolution advocating for explainable AI tools in radiology and other fields.
- 2The association calls for third-party oversight of AI algorithms rather than relying solely on vendor claims.
- 3AMA emphasizes the need for detailed explanations of AI outputs, especially given potential 'life or death consequences.'
- 4Intellectual property concerns should not outweigh the need for explainable AI in medicine.
- 5Lack of explainability may put physicians in difficult positions and undermine their clinical judgment.
Why It Matters
The AMA's stance highlights the critical need for trustworthy AI tools in radiology, impacting both provider decision-making and patient care. Increased transparency and oversight may shape future AI regulations, adoption, and industry practices.
Source
Radiology Business
Related News
•Radiology Business
FDA-Cleared Imaging AI Proliferates, But Reimbursement Stalls
Despite a surge in FDA-cleared radiology AI tools, very few qualify for reimbursement due to lack of supporting clinical studies.
•HealthExec
Lawsuit Alleges AI Note-Taking Tool Secretly Recorded Patient Exams
Sharp HealthCare faces a lawsuit for allegedly using AI to record patient-clinician conversations without consent.
•HealthExec
US Executive Order and HHS Strategy Set AI Policy Directions for Healthcare
The White House executive order and new HHS strategy shift US policy towards unified AI standards and expanded adoption in healthcare.